HomeBUSINESS
BUSINESS

Torii’s Futhan to Get 43.4% Price Cut in April, Urinorm 24.6%: Top 5 Product Survey
(Mar.8.2018)

Torii Pharmaceutical’s mainstay protease inhibitor Futhan 50 Injection 50 mg (nafamostat) will be slammed with a whopping 43.4% price cut in April under a revamped re-pricing scheme for off-patent original drugs, according to a Jiho survey, which looked into the impact of the FY2018 price revision on drug makers’ top five products ...
(LOG IN FOR FULL STORY)